GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals. GE HealthCare's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition. GE HealthCare was originally the healthcare division of the American conglomerate General Electric, which spun it off in 2023 as an independent, publicly traded company. It operates in more than 100 countries, with GE HealthCare major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India.